Shelton Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.12M Hold
182,411
0.11% 145
2025
Q4
$4.54M Sell
182,411
-523
-0.3% -$13.2K 0.09% 169
2025
Q3
$4.66M Sell
182,934
-543
-0.3% -$13.4K 0.1% 160
2025
Q2
$4.45M Buy
183,477
+4,951
+3% +$115K 0.1% 174
2025
Q1
$4.52M Buy
178,526
+11,342
+7% +$297K 0.11% 159
2024
Q4
$4.44M Sell
167,184
-1,098
-0.7% -$29.8K 0.11% 166
2024
Q3
$4.87M Sell
168,282
-5,368
-3% -$157K 0.13% 152
2024
Q2
$4.86M Sell
173,650
-59,803
-26% -$1.65M 0.13% 150
2024
Q1
$6.48M Sell
233,453
-102,790
-31% -$2.85M 0.18% 128
2023
Q4
$9.68M Sell
336,243
-11,919
-3% -$360K 0.31% 74
2023
Q3
$11.5M Sell
348,162
-6,290
-2% -$222K 0.42% 47
2023
Q2
$13M Buy
354,452
+6,912
+2% +$269K 0.47% 43
2023
Q1
$14.2M Buy
347,540
+198,540
+133% +$8.58M 0.59% 28
2022
Q4
$7.63M Sell
149,000
-2,469
-2% -$118K 0.8% 18
2022
Q3
$6.63M Sell
151,469
-1,312
-0.9% -$63.8K 0.32% 82
2022
Q2
$8.01M Buy
152,781
+34,792
+29% +$1.77M 0.36% 72
2022
Q1
$6.11M Buy
117,989
+71,331
+153% +$3.7M 0.23% 98
2021
Q4
$2.75M Buy
46,658
+805
+2% +$39.9K 0.1% 209
2021
Q3
$1.97M Sell
45,853
-295
-0.6% -$13.1K 0.08% 228
2021
Q2
$1.81M Sell
46,148
-164,636
-78% -$6.4M 0.07% 235
2021
Q1
$7.64M Buy
210,784
+103,196
+96% +$3.66M 0.27% 82
2020
Q4
$3.96M Sell
107,588
-5,995
-5% -$220K 0.18% 120
2020
Q3
$3.96M Sell
113,583
-527
-0.5% -$18.5K 0.16% 141
2020
Q2
$3.54M Buy
114,110
+20,342
+22% +$691K 0.2% 105
2020
Q1
$2.9M Sell
93,768
-8,072
-8% -$275K 0.21% 96
2019
Q4
$3.79M Sell
101,840
-158,537
-61% -$5.65M 0.21% 98
2019
Q3
$8.88M Sell
260,377
-4,111
-2% -$149K 0.52% 45
2019
Q2
$10.9M Buy
264,488
+254,762
+2,619% +$10.1M 0.63% 33
2019
Q1
$217K Sell
9,726
-193,776
-95% -$7.76M 0.86% 16
2018
Q4
$8.43M Sell
203,502
-28,564
-12% -$1.19M 0.57% 39
2018
Q3
$9.7M Buy
232,066
+163,100
+236% +$6.28M 0.55% 41
2018
Q2
$2.37M Buy
68,966
+2,835
+4% +$96.9K 0.15% 138
2018
Q1
$2.23M Sell
66,131
-4,437
-6% -$153K 0.15% 138
2017
Q4
$2.42M Sell
70,568
-5,679
-7% -$194K 0.16% 132
2017
Q3
$2.58M Sell
76,247
-94,516
-55% -$3.04M 0.17% 127
2017
Q2
$5.44M Sell
170,763
-28,354
-14% -$894K 0.38% 57
2017
Q1
$6.46M Buy
199,117
+32,642
+20% +$1.03M 0.45% 40
2016
Q4
$5.13M Buy
166,475
+52,115
+46% +$1.59M 0.39% 46
2016
Q3
$3.67M Buy
114,360
+36,850
+48% +$1.23M 0.31% 65
2016
Q2
$2.59M Sell
77,510
-4,586
-6% -$146K 0.23% 84
2016
Q1
$2.31M Buy
82,096
+7,276
+10% +$208K 0.21% 93
2015
Q4
$2.29M Buy
74,820
+13,050
+21% +$411K 0.22% 95
2015
Q3
$1.84M Buy
61,770
+5,826
+10% +$187K 0.2% 102
2015
Q2
$1.78M Sell
55,944
-3,313
-6% -$108K 0.18% 110
2015
Q1
$1.96M Buy
59,257
+488
+0.8% +$15.5K 0.21% 101
2014
Q4
$1.74M Sell
58,769
-13,491
-19% -$387K 0.2% 103
2014
Q3
$2.03M Buy
72,260
+13,305
+23% +$373K 0.27% 81
2014
Q2
$1.66M Sell
58,955
-527
-0.9% -$15K 0.23% 89
2014
Q1
$1.81M Buy
59,482
+1,897
+3% +$56.6K 0.27% 82
2013
Q4
$1.67M Sell
57,585
-6,219
-10% -$181K 0.25% 84
2013
Q3
$1.74M Sell
63,804
-2,134
-3% -$58.1K 0.29% 74
2013
Q2
$1.75M Buy
+65,938
New +$1.82M 0.32% 74

Other funds holding PFE

Shelton Capital Management's PFE Position: Q1 2026 in Review

Shelton Capital Management held its Pfizer (PFE) position steady in Q1 2026 at 182,411 shares worth $5.12M. The position accounts for 0.11% of the portfolio, ranked #145.

Shelton Capital Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.2M in Q1 2023. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Shelton Capital Management held 182,411 shares of Pfizer worth $5.12M as of Q1 2026.
  • Shelton Capital Management left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.11% of Shelton Capital Management's portfolio in Q1 2026, its #145 holding.
  • Shelton Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Shelton Capital Management's Pfizer position peaked at $14.2M in Q1 2023.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Shelton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.